139 related articles for article (PubMed ID: 1508841)
21. Experimental study of renal disorder caused by oxaliplatin in rat renal cortical slices.
Kanou T; Uozumi J; Soejima K; Tokuda Y; Masaki Z
Clin Exp Nephrol; 2004 Dec; 8(4):310-5. PubMed ID: 15619029
[TBL] [Abstract][Full Text] [Related]
22. Iron- and ascorbic acid-induced lipid peroxidation in renal microsomes isolated from rats treated with platinum compounds.
Hannemann J; Duwe J; Baumann K
Cancer Chemother Pharmacol; 1991; 28(6):427-33. PubMed ID: 1934247
[TBL] [Abstract][Full Text] [Related]
23. The role of the renin-angiotensin system in cisplatin nephrotoxicity.
Deegan PM; Nolan C; Ryan MP; Basinger MA; Jones MM; Hande KR
Ren Fail; 1995 Nov; 17(6):665-74. PubMed ID: 8771239
[TBL] [Abstract][Full Text] [Related]
24. The renal fractional clearance of platinum antitumour compounds in relation to nephrotoxicity.
Daley-Yates PT; McBrien DC
Biochem Pharmacol; 1985 May; 34(9):1423-8. PubMed ID: 4039567
[TBL] [Abstract][Full Text] [Related]
25. Lack of nephrotoxicity of oral ammine/amine platinum (IV) dicarboxylate complexes in rodents.
McKeage MJ; Morgan SE; Boxall FE; Murrer BA; Hard GC; Harrap KR
Br J Cancer; 1993 May; 67(5):996-1000. PubMed ID: 8494733
[TBL] [Abstract][Full Text] [Related]
26. [Experimental study on carboplatin toxicity--a comparison with cisplatin].
Suzuki K; Usami T; Sudoko H; Ohtawara Y; Tajima A; Kawabe K; Aso Y
Gan To Kagaku Ryoho; 1988 Jul; 15(7):2153-8. PubMed ID: 3293538
[TBL] [Abstract][Full Text] [Related]
27. [Studies on adequate intervals of cisplatin administration to ameliorate cisplatin-induced nephrotoxicity].
Sakatoku H; Kawai K; Kamiya H; Sakurai M
Gan To Kagaku Ryoho; 1986 Feb; 13(2):239-46. PubMed ID: 3947105
[TBL] [Abstract][Full Text] [Related]
28. Attenuation of cisplatin nephrotoxicity by streptozotocin-induced diabetes.
Scott LA; Madan E; Valentovic MA
Fundam Appl Toxicol; 1989 Apr; 12(3):530-9. PubMed ID: 2731667
[TBL] [Abstract][Full Text] [Related]
29. [Prophylactic effect of methylprednisolone on cisplatin-induced nephrotoxicity].
Koikawa Y
Fukuoka Igaku Zasshi; 1995 Feb; 86(2):31-9. PubMed ID: 7729781
[TBL] [Abstract][Full Text] [Related]
30. [Prophylactic effect of methylprednisolone on cisplatin-induced nephrotoxicity in rats].
Koikawa Y; Uozumi J; Yasumasu T; Ueda T; Kumazawa J
Gan To Kagaku Ryoho; 1993 Aug; 20(10):1363-7. PubMed ID: 8346934
[TBL] [Abstract][Full Text] [Related]
31. Inductively coupled plasma mass spectroscopy quantitation of platinum-DNA adducts in peripheral blood leukocytes of patients receiving cisplatin- or carboplatin-based chemotherapy.
Bonetti A; Apostoli P; Zaninelli M; Pavanel F; Colombatti M; Cetto GL; Franceschi T; Sperotto L; Leone R
Clin Cancer Res; 1996 Nov; 2(11):1829-35. PubMed ID: 9816137
[TBL] [Abstract][Full Text] [Related]
32. Failure of a 21-aminosteroid antioxidant to ameliorate cisplatin-induced nephrotoxicity.
Holding JD; Stell PM; Lindup WE
Hum Exp Toxicol; 1991 Sep; 10(5):323-6. PubMed ID: 1683544
[TBL] [Abstract][Full Text] [Related]
33. Nephrotoxicity of cisplatin, carboplatin and transplatin. A comparative in vitro study.
Hannemann J; Baumann K
Arch Toxicol; 1990; 64(5):393-400. PubMed ID: 2169720
[TBL] [Abstract][Full Text] [Related]
34. Methylprednisolone reduces the nephrotoxicity caused by cisplatin.
Uozumi J; Koikawa Y; Ueda T
J Pharmacobiodyn; 1992 Dec; 15(12):693-7. PubMed ID: 1296980
[TBL] [Abstract][Full Text] [Related]
35. A comparison of the effects of cisplatin and N-methyliminodiacetato-(1,2-diaminocyclohexane)-platinum(II) on renal function and gentamicin excretion in rats.
Engineer MS; Ho DH; Khokhar AR; Newman RA; Bulger RE
Toxicology; 1987 Dec; 47(3):307-15. PubMed ID: 3424386
[TBL] [Abstract][Full Text] [Related]
36. Dose response of carboplatin-induced nephrotoxicity in rats.
Husai K; Jagannathan R; Hasan Z; Trammell GL; Rybak LP; Hazelrigg SR; Somani SM
Pharmacol Toxicol; 2002 Aug; 91(2):83-9. PubMed ID: 12420797
[TBL] [Abstract][Full Text] [Related]
37. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
[TBL] [Abstract][Full Text] [Related]
38. Clinical pharmacokinetics of carboplatin.
van der Vijgh WJ
Clin Pharmacokinet; 1991 Oct; 21(4):242-61. PubMed ID: 1760899
[TBL] [Abstract][Full Text] [Related]
39. Reduction of cisplatin nephrotoxicity by procainamide: does the formation of a cisplatin-procainamide complex play a role?
Viale M; Vannozzi MO; Pastrone I; Mariggiò MA; Zicca A; Cadoni A; Cafaggi S; Tolino G; Lunardi G; Civalleri D; Lindup WE; Esposito M
J Pharmacol Exp Ther; 2000 Jun; 293(3):829-36. PubMed ID: 10869382
[TBL] [Abstract][Full Text] [Related]
40. Effects of the diuretics mannitol or acetazolamide on nephrotoxicity and physiological disposition of cisplatin in rats.
Osman NM; Copley MP; Litterst CL
Cancer Chemother Pharmacol; 1984; 13(1):58-62. PubMed ID: 6428763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
